Informed Consent in Acute Coronary Syndrome Trials
At what point, and under what circumstances, should trial participation be allowed to proceed without some discussion of consent? And…
At what point, and under what circumstances, should trial participation be allowed to proceed without some discussion of consent? And…
At a time when so many aspects of our everyday lives are influenced and enhanced by digital technology, it is clear…
Given the increased number of global regulatory and standards-based guidance documents issued over recent years, members of the pharmaceutical supply chain…
Healthcare is moving towards a patient-centric model, demanding a corresponding shift in clinical research design to reflect the incorporation of the…
Melanoma, arising predominantly from clonally multiplying pigment cells, may rapidly become metastatic and spread to secondary organs (the lungs, liver, brain, pleura).…
Are there more drugs approved? Is the regulatory pathway to getting a drug to market as a treatment for HD…
South Africa is considered a clinical research “hot spot” due to its diverse genetic, drug-naive patient population, known for supplying high-quality…
All sub-Saharan countries, including Botswana, South Africa and Zimbabwe, face a severe HIV and AIDS epidemic. As many authors have…
Matan Topper-Erez of TransCom Global explores the challenges raised by conducting clinical trials in Israel, an ever-popular destination for multinational clinical…
Readers of previous articles in this series have seen John Faulkes of Agio Interactive discuss a range of critical factors…